Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer

BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are commonly prescribed because of their therapeutic and preventive effects on cardiovascular diseases. Even though they have been occasionally reported to have antitumour activity, it is unknown whether statins have an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S J, Lee, I, Lee, J, Park, C, Kang, W K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119970/
https://www.ncbi.nlm.nih.gov/pubmed/24945998
http://dx.doi.org/10.1038/bjc.2014.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119970/
https://www.ncbi.nlm.nih.gov/pubmed/24945998
http://dx.doi.org/10.1038/bjc.2014.283

Ejemplares similares